Susan M Geyer

5PUBLICATIONS

62CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyPredictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 26, 2026

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Jun 09, 2026

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

|May 10, 2026

Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype.

|Jan 16, 2026

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Priscilla K Brastianos, Katharine Dooley, Susan Geyer

|Feb 16, 2024

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon

Pageof 1

Frequent Collaborators

Saurabh Chhabra

Priya Kumthekar

S Vincent Rajkumar

Joselle Cook

Morie Gertz

Priscilla K Brastianos

1 joint publications

Katharine Dooley

1 joint publications

Carlos Kamiya Matsuoka

1 joint publications

Kurt Jaeckle

1 joint publications

Ian Rabinowitz

Frequent Collaborators

Saurabh Chhabra

Priya Kumthekar

S Vincent Rajkumar

Joselle Cook